Extended survival and pronostic criteria for acemannan (ACE-M) treated HIV-1 patients(pts) : McDaniel, HR∗; Carpenter, RH∗∗; Kemp, M∗∗∗ Kahlon, J∗∗∗∗; McAnalley, B. ∗∗∗Dallas-Ft. Worth Medical Center, Grand Prairie, Texas, USA, ∗∗Carrington Labs, Inc., Irving, Texas, USA, ∗∗∗Texas A&M University, College Station, Texas, USA, ∗∗∗∗Southern Research Institute, Birmingham, Alabama, USA